Report Overview
The Flocculants market is forecast to grow at a CAGR of 6.3%, reaching USD 14.0 billion in 2031 from USD 10.3 billion in 2026.
The Asia-Pacific region is the fastest-growing market for flocculants due to rapid industrialization, urbanization, and increasing demand for water and wastewater treatment in countries like China and India.
Among types, organic flocculants are the fastest-growing segment due to their high efficiency and wide industrial applicability.
In 2025, anionic flocculants were the major segment by charge type, accounting for % share by value, followed by the cationic flocculants, contributing to % share in the same year.
Anionic flocculants are the fastest-growing segment under charge type, driven by their widespread use in wastewater treatment and mining applications due to high efficiency in solid-liquid separation.
Water Treatment and Processing is the fastest-growing application segment, driven by increasing demand for clean water and large-scale municipal and industrial treatment needs.
In industry verticals, the mining sector is witnessing the highest growth, driven by increasing mineral processing and water recovery needs.
Market Dynamics
Drivers
Rising Demand for Water and Wastewater Treatment
One of the key factors driving the global flocculants market is the growing need for water and wastewater treatment, accelerated by escalating water scarcity, urbanization, and industrial discharges that cause pollution worldwide. With freshwater resources becoming increasingly limited, both governments and industries have been prioritizing more efficient water management schemes, such as wastewater recycling and reuse.
About 30% of the EU's land area is experiencing water stress, while almost half of the surface water in the Member States did not comply with pollution quality standards, thus threatening human health.
Growing public awareness is leading to mounting pressure to tackle the issue of pollution. According to a recent study from the European Commission, 69% of Europeans believe that pollution is the main cause of water-related issues.
Half of the global population might be residing in regions with water scarcity in 2025, as per the UNICEF report.
Around 700 million people could be forced to relocate their homes due to severe water scarcity by 2030.
In 2040, according to UNICEF, about one-quarter of the world's children will be living in highly water-stressed areas.
According to the Annual Ground Water Quality Report, 2025 issued by the CGWB, a total of 3, 415 groundwater samples from 26 States/UTs in India were collected and analyzed by CGWB for Arsenic, while 2, 537 samples from 21 States/UTs were analyzed for lead during Pre-Monsoon and Post-Monsoon.
The analysis showed that 123 samples (3.6%), out of 3,415, were above the permissible limit of 10 ppb for Arsenic, whereas 24 samples (0.95%), out of 2, 537, were above the permissible limit of 0.01 mg/L for Lead.
Key Developments
2024: Tallinna Vesi made a conscious decision to switch from conventional polymers to Kemira´s new Superfloc® BioMB to further support their sustainability targets.
Market Segmentation
By Industry Vertical: Oil and Gas
The flocculants market is expanding across industry verticals as water treatment requirements are increasing in response to tightening environmental discharge norms and rising industrial output.
By Industry Vertical, mining dominates demand as large-scale mineral processing generates high volumes of slurry requiring efficient solid-liquid separation. Also, the food and beverage and pulp and paper sectors rely on flocculants to meet discharge standards while maintaining operational efficiency. Chemical processing industries are adopting advanced formulations to handle complex effluents with variable compositions. The outcome is a diversified demand base where performance requirements vary significantly by industry, driving continuous product innovation.
The oil and gas segment is estimated to grow at a CAGR of % and reach a market size worth USD billion by 2031 from an initial value of USD billion in 2026. Demand is shifting toward high-performance flocculants as operators are improving solid-liquid separation to maintain operational continuity. Additionally, manufacturers are developing customized flocculant solutions aligned with field-specific conditions. The outcome is a demand structure driven by regulatory pressure, operational efficiency, and water management optimization.
The oil & gas sector is adopting advanced flocculants as produced water treatment requirements are increasing under stricter environmental regulations. In 2025, the United States had an average import of approximately 490,000 barrels per day of crude oil from the Middle East Gulf region, comprising Bahrain, Iraq, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates.
Increasing offshore and unconventional exploration is driving demand for high-efficiency separation chemicals as water volumes and contamination complexity are rising. In January 2026, SNF announced that it had completed the previously announced acquisition of Syensqo’s Oil & Gas division for an Enterprise Value of €135 million.
Operators are prioritizing chemical formulations that reduce sludge generation and disposal costs, improving overall operational efficiency.
Government regulations on discharge standards are tightening, which is pushing oil & gas companies to adopt advanced water treatment chemicals. The United States Environmental Protection Agency enforces strict effluent limitation guidelines for oil & gas discharges, driving operators to implement high-performance flocculants to meet compliance thresholds.
Collaborations between chemical manufacturers and oilfield service providers are accelerating the development of customized flocculant solutions. For instance, in November 2024, Solenis, a leading global producer of specialty chemicals, acquired BASF’s flocculants business for mining applications. This strategic acquisition enhances Solenis’ portfolio, ensuring a comprehensive solution for its mining and mineral processing customers.
Regional Analysis
North America: the US
With a well-established wastewater treatment system followed by efforts undertaken to further expand municipal treatment capacity in major states, namely California, New York, Texas, and Washington, the market growth has been amplified.
Implementation of treatment optimization programs like “Area Wide Optimization Program” by Environment Protection Agency (EPA) will further enhance the existing water treatment operations in the USA, thereby providing new growth prospects for flocculants.
Well-established presence of major market players, such as Kemira, SNF Group, Ecolab Inc., and Clariant, which have shown constant investment in innovations to meet the market dynamics, has established a new market landscape.
Ongoing industrial expansion, coupled with investments undertaken under the CHIPS & Science Act to bolster domestic semiconductor production, is set to improve flocculants demand for wastewater treatment in the USA.
Development in mobile water-treatment units, followed by efforts to invest in farm modernization by concerned authorities, provides new opportunities in flocculants usage.
With improved strength of mining establishments, the growth of flocculants adoption further improves. According to the U.S Bureau of Labor Statistics, in Q3 2025, the total number of mining establishments reached 7,417, marking an addition of 41 establishments.
List of Companies
Kemira Oyj
Ecolab Inc.
Solenis LLC
Kurita Water Industries Ltd.
Ixom
Clariant AG
Yixing Bluwat Chemicals Co., Ltd.
Buckman Laboratories International, Inc.
Feralco Group
Nouryon B.V.
Kemira Oyj participates in the flocculant market as a leading provider of high-performance organic polymers, primarily polyacrylamides, for solid-liquid separation in municipal and industrial water treatment. The company integrates flocculants with its strong coagulant portfolio to deliver complete solutions for water clarification, sludge dewatering, and process optimization. Its strategy emphasizes application expertise, offering a wide range of charge densities and molecular weights in both powder and emulsion forms to meet diverse customer needs across wastewater, raw water, and industrial effluents. Kemira focuses on supply reliability through a robust manufacturing footprint near key markets in Europe and North America.
It positions itself as a trusted partner by combining chemistry with technical service, helping customers improve operational efficiency, reduce sludge volumes, and achieve better water quality. The approach highlights sustainable chemistry, including biomass-balanced options, while maintaining performance parity with conventional products. By prioritizing customer-centric innovation and long-term relationships, Kemira strengthens its role in resource-efficient water management for urban utilities and water-intensive industries.
Flocculants Market Scope:
| Report Metric | Details |
|---|---|
| Total Market Size in 2026 | USD 10.3 billion |
| Total Market Size in 2031 | USD 14.0 billion |
| Growth Rate | 6.3% |
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Segmentation | Type, Charge Type, Application, Geography |
| Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| Companies |
|
Market Segmentation
Type
Charge Type
Application
Geography
Geographical Segmentation
North America, South America, Europe, Middle East and Africa, Asia Pacific
Table of Contents
1. EXECUTIVE SUMMARY
1.1 Market Snapshot
1.2 Key Findings
1.3 Analyst Insights
1.4 Strategic Recommendations
2. RESEARCH METHODOLOGY
2.1 Research Design
2.2 Data Collection
2.3 Market Size Estimation
2.4 Forecasting Model
2.5 Assumptions & Limitations
3. MARKET OVERVIEW, SIZE, AND FORECAST
3.1 Market Introduction
3.2 Market Definition & Scope
3.3 Evolution of the Industry
3.4 Key Trends Shaping the Market
3.4 Global Market Size
3.5 Forecast
3.6. Prevalence Data
4. MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges
5. BUSINESS LANDSCAPE
5.1 Industry Value Chain Analysis
5.2 Pricing Analysis
5.3 Reimbursement Scenario
6. TECHNOLOGICAL LANDSCAPE
6.1 Emerging Technologies
6.2 Pipeline Analysis
6.3 AI / Digital Health Integration
7. REGULATORY FRAMEWORK
7.1 FDA / EMA / CDSCO Guidelines
7.2 Approval Processes
7.3 Compliance Requirements
8. MARKET SEGMENTATION
8.1 By Platform Type
8.1.1 mRNA Platforms
8.1.2 DNA Platforms
8.1.3 Viral Vector Platforms
8.1.4 Protein Subunit Platforms
8.1.5 Nanoparticle Platforms
8.1.6 Others
8.2 By Target Disease
8.2.1 Influenza
8.2.2 Coronavirus
8.2.3 HIV
8.2.4 Cancer Vaccines
8.2.5 Others
8.3 By Stage of Development
8.3.1 Preclinical
8.3.2 Phase I
8.3.3 Phase II
8.3.4 Phase III
8.3.5 Commercialized
8.4 By End-User
8.4.1 Pharmaceutical & Biotechnology Companies
8.4.2 Research Institutes
8.4.3 Government & Defense Organizations
8.4.4 Contract Research Organizations (CROs)
9. GEOGRAPHICAL ANALYSIS
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 South America
9.5 Middle East & Africa
10. COUNTRY ANALYSIS
10.1 United States
10.2 Germany
10.3 United Kingdom
10.4 China
10.5 Japan
10.6 India
10.7 South Korea
10.8 Canada
10.9 Australia
10.10 Switzerland
10.11 France
10.12 Singapore
10.13 Israel
10.14 Brazil
11. COMPETITIVE LANDSCAPE
11.1 Market Share Analysis
11.2 Competitive Benchmarking
11.3 Strategic Developments
11.4 Mergers & Acquisitions
11.5 Partnerships
11.6 Product Launches
12. COMPANY PROFILES
12.1 Moderna
12.1.1. Overview
12.1.2. Financials
12.1.3. Product Portfolio
12.1.4. Recent Developments
12.2 Pfizer / BioNTech
12.2.1. Overview
12.2.2. Financials
12.2.3. Product Portfolio
12.2.4. Recent Developments
12.3 CureVac
12.3.1. Overview
12.3.2. Financials
12.3.3. Product Portfolio
12.3.4. Recent Developments
12.4 GSK
12.4.1. Overview
12.4.2. Financials
12.4.3. Product Portfolio
12.4.4. Recent Developments
12.5 Sanofi
12.5.1. Overview
12.5.2. Financials
12.5.3. Product Portfolio
12.5.4. Recent Developments
12.6 AstraZeneca
12.6.1. Overview
12.6.2. Financials
12.6.3. Product Portfolio
12.6.4. Recent Developments
12.7 Novavax
12.7.1. Overview
12.7.2. Financials
12.7.3. Product Portfolio
12.7.4. Recent Developments
12.8 Inovio Pharmaceuticals
12.8.1. Overview
12.8.2. Financials
12.8.3. Product Portfolio
12.8.4. Recent Developments
12.9 VBI Vaccines
12.9.1. Overview
12.9.2. Financials
12.9.3. Product Portfolio
12.9.4. Recent Developments
12.10 Arcturus Therapeutics
12.10.1. Overview
12.10.2. Financials
12.10.3. Product Portfolio
12.10.4. Recent Developments
12.11 Gritstone Bio
12.11.1. Overview
12.11.2. Financials
12.11.3. Product Portfolio
12.11.4. Recent Developments
12.12 GeoVax Labs
12.12.1. Overview
12.12.2. Financials
12.12.3. Product Portfolio
12.12.4. Recent Developments
13. INVESTMENT & FUNDING ANALYSIS
13.1. Venture Capital Trends
13.2. Government Funding
13.3. R&D Investments
14. FUTURE OUTLOOK
14.1. Key Growth Areas
14.2. Disruptive Trends
Request Customization
Tell us your specific requirements and we will customize this report for you.
Download Free Sample
Get a sample copy of this report with charts, TOC, and methodology.
Speak to Analyst
Ask our analysts any questions you have about this market research report.
Flocculants Market Report
Trusted by the world's leading organizations











